Integer Holdings Corporation (ITGR) saw its stock price surge 5.02% during intraday trading on Thursday. The medical device contract manufacturer experienced significant buying interest following major corporate announcements.

The company announced that its Board of Directors has initiated a strategic review to maximize stockholder value. In consultation with financial and legal advisors, the Board will consider a full range of potential opportunities including, but not limited to, a sale, merger, or strategic business combination. This news typically generates investor optimism about potential premium valuations in acquisition scenarios or other value-creating transactions.

Additionally, Integer reported first quarter 2026 results that exceeded analyst expectations. The company posted adjusted earnings of $1.20 per share, beating the consensus estimate of $1.19, while sales of $439.6 million surpassed expectations of $426.5 million. Although the company lowered its full-year 2026 guidance, management reiterated its expectation to return to 200 basis points above-market organic sales growth in 2027, providing a positive longer-term outlook.